Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Breast Neoplasms 278Carcinoma, Non-Small-Cell Lung 228Prostatic Neoplasms 183Neoplasms 180Multiple Myeloma 140Lung Neoplasms 137Neoplasm Metastasis 104Colorectal Neoplasms 101Melanoma 87Ovarian Neoplasms 86Leukemia, Myeloid, Acute 78Pancreatic Neoplasms 73Lymphoma 72Leukemia, Lymphocytic, Chronic, B-Cell 67Carcinoma, Renal Cell 65Squamous Cell Carcinoma of Head and Neck 64Lymphoma, Non-Hodgkin 64Brain Neoplasms 64Recurrence 57Urinary Bladder Neoplasms 56Carcinoma, Hepatocellular 56Hematologic Neoplasms 55Head and Neck Neoplasms 55Triple Negative Breast Neoplasms 52Lymphoma, Follicular 49Glioblastoma 49Endometrial Neoplasms 48Uterine Cervical Neoplasms 47Precursor Cell Lymphoblastic Leukemia-Lymphoma 47Sarcoma 44

Interventions

atezolizumab 1Etoposide 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × SCLC,Extensive Stage × 90 days × Clear all
NCT05595460 2026-04-13

Study of RYZ101 in Combination With SoC in Subjects With SSTR+ ES-SCLC

RayzeBio, Inc.

Phase 1 Active not recruiting
21 enrolled
Thoracic

SCLC,Extensive Stage

Data powered by HemOnc (CC BY 4.0) Colophon âš¡